Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling gsk'

Search results for: 'research area pi3k akt signaling gsk'

Items 11-20 of 110

Page
per page
  1. GSK 2837808A
    B4929 GSK 2837808A
    Target: Lactate Dehydrogenases (LDH)
    Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor
      ≥9.12 mg/mL
  2. XL147
    A5112 XL147
    Target: PI3K
    Summary: PI3K inhibitor,selective and reversible
      ≥22.45 mg/mL
  3. GSK 4112
    B7460 GSK 4112
    Target: Rev-Erb Receptors
    Summary: Rev-Erbα agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  4. GSK 650394
    B1051 GSK 650394
     2 Citation
    Target: SGK
    Summary: SGK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.1 mg/mL
  5. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  6. AZD8055
    A8214 AZD8055
     2 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL
  7. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
  8. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  9. VS-5584 (SB2343)
    A3927 VS-5584 (SB2343)
    Target: PI3K|mTOR
    Summary: MTOR/P13K inhibitor,potent and selective
      insoluble in H2O; ≥17.7 mg/mL
  10. AS-605240
    A5176 AS-605240
    Target: PI3K
    Summary: Potent and selective PI 3-Kγ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.28 mg/mL

Items 11-20 of 110

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 2item
  2. Apoptosis 1 item
  3. Chromatin/Epigenetics 4item
  4. Metabolism 5item
  5. MAPK Signaling 20item
  6. Tyrosine Kinase 9item
  7. DNA Damage/DNA Repair 6item
  8. PI3K/Akt/mTOR Signaling 39item
  9. Cell Cycle/Checkpoint 3item
  10. Ubiquitination/ Proteasome 2item
  11. JAK/STAT Signaling 8item
  12. TGF-β / Smad Signaling 12item
  13. GPCR/G protein 1 item
  14. Stem Cell 17item
  15. Membrane Transporter/Ion Channel 1 item
  16. Endocrinology and Hormones 1 item
  17. Neuroscience 3item
  18. Obesity, Appetite Control & Diabetes 2item
  19. Other Signal Transduction 2item
  20. Others 2item
  21. Immunology/Inflammation 1 item
  22. Cardiovascular 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 5item
  4. PI3K 22item
  5. Raf 6item
  6. EZH2 2item
  7. mTOR 10item
  8. Androgen Receptors 1 item
  9. FLT3 1 item
  10. GSK-3 9item
  11. P-glycoprotein (P-gp) 1 item
  12. PLK 1 item
  13. Chk 1 item
  14. VEGFR 3item
  15. PDGFR 2item
  16. Phosphodiesterases (PDEs) 1 item
  17. p38 4item
  18. PKB 1 item
  19. JNK 4item
  20. SGK 1 item
  21. MEK 6item
  22. PORCN 1 item
  23. FGFR 1 item
  24. GABAB Receptors 1 item
  25. Smoothened 1 item
  26. STAT 4item
  27. EGFR 2item
  28. Hedgehog 1 item
  29. BMP and Other Activin Receptors 2item
  30. JAK 2item
  31. Syk 1 item
  32. DNA-PK 4item
  33. HSP90 1 item
  34. TNKS 1 item
  35. Toll-like receptors (TLRs) 1 item
  36. ERK 1 item
  37. PKC 3item
  38. Melanocortin (MC) Receptors 1 item
  39. Lactate Dehydrogenases (LDH) 1 item
  40. Fatty-acid-binding proteins (FABPs) 1 item
  41. Free Fatty Acid Receptors 1 item
  42. NO Donors / Precursors 1 item
  43. IL Receptors 1 item
  44. Rev-Erb Receptors 1 item
  45. PKD 1 item
  46. ATM 1 item
Reported Experiments
  1. Animal Experiments 100item
  2. Cell Experiments 64item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 24item
  5. Cancer 70item
  6. Cervical Cancer 2item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 10item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 11item
  12. Diabetes 1 item
  13. Glioblastoma 11item
  14. Glioma 4item
  15. Hepatocellular Carcinoma 1 item
  16. Leukemia 5item
  17. Liver Cancer 1 item
  18. Lung Cancer 8item
  19. Lymphoma 2item
  20. Melanoma 7item
  21. Multiple Myeloma 1 item
  22. Myeloma 1 item
  23. Neuroblastoma 2item
  24. Non-small Cell Lung Cancer 6item
  25. Ovarian Cancer 8item
  26. Pancreatic Cancer 9item
  27. Pancreatic Carcinoma 2item
  28. Prostate Cancer 13item
  29. Pulmonary Arterial Hypertension 1 item
  30. Pulmonary Fibrosis 1 item
  31. Renal Cancer 2item
  32. Rheumatoid Arthritis 2item
  33. Thyroid Cancer 2item
  34. Type 2 Diabetes 2item